Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Clot Management devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. GlobalData uses proprietary data and analytics to provide a comprehensive report on the clot management devices devices market, including market shares of different players within Israel. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the clot management devices market in Israel was Boston Scientific followed by Medtronic, Cook Medical, Penumbra, Teleflex, AngioDynamics, Becton Dickinson and Co, Argon Medical Devices, Merit Medical Systems, Koninklijke Philips, Terumo and Edwards Lifesciences.
The Clot Management Device is used in a routine procedure while performing Percutaneous Coronary Intervention and to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This category includes Inferior Vena Cava Filter (IVCF), Embolectomy Balloon Catheters, Manual Aspiration Thrombectomy Devices, Rotational Thrombectomy Devices, Thrombectomy Systems (Catheters) and CDT Catheters.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the clot management devices devices market within Israel was expected to be over $4m in 2022.
For the latest complete market share analysis of clot management devices device market in Israel, buy the report here.